Home/Filings/4/0001209191-18-062948
4//SEC Filing

Michelon Francois Roger 4

Accession 0001209191-18-062948

CIK 0001681682other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 4:36 PM ET

Size

5.4 KB

Accession

0001209191-18-062948

Insider Transaction Report

Form 4
Period: 2018-12-13
Michelon Francois Roger
DirectorChief Executive Officer
Transactions
  • Award

    Stock Options

    2018-12-13+125,000125,000 total
    Exercise: $2.25Exp: 2026-12-13Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]These Stock Options become exercisable in three equal annual installments beginning on December 13, 2019.

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1
  • filerCIK 0001691470

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:36 PM ET
Size
5.4 KB